Correlation Between Humacyte and CareMax

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Humacyte and CareMax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Humacyte and CareMax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Humacyte and CareMax, you can compare the effects of market volatilities on Humacyte and CareMax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Humacyte with a short position of CareMax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Humacyte and CareMax.

Diversification Opportunities for Humacyte and CareMax

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Humacyte and CareMax is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Humacyte and CareMax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CareMax and Humacyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Humacyte are associated (or correlated) with CareMax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CareMax has no effect on the direction of Humacyte i.e., Humacyte and CareMax go up and down completely randomly.

Pair Corralation between Humacyte and CareMax

Assuming the 90 days horizon Humacyte is expected to generate 0.43 times more return on investment than CareMax. However, Humacyte is 2.35 times less risky than CareMax. It trades about 0.07 of its potential returns per unit of risk. CareMax is currently generating about -0.02 per unit of risk. If you would invest  85.00  in Humacyte on September 1, 2024 and sell it today you would earn a total of  62.00  from holding Humacyte or generate 72.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Humacyte  vs.  CareMax

 Performance 
       Timeline  
Humacyte 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Humacyte are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Humacyte may actually be approaching a critical reversion point that can send shares even higher in December 2024.
CareMax 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CareMax has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Humacyte and CareMax Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Humacyte and CareMax

The main advantage of trading using opposite Humacyte and CareMax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Humacyte position performs unexpectedly, CareMax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CareMax will offset losses from the drop in CareMax's long position.
The idea behind Humacyte and CareMax pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios